Interclean Shanghai

China’s Luye Medical to buy Australian Private-Hospital Operator, Healthe Care Australia Pty. Ltd

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...
Healthe Care Australia Pty. Ltd., one of the country’s largest private-hospital operators, will be bought from private equity owner Archer Capital by China’s Luye Medical Group Co. for 938 million Australian dollars (US$688 million).

The health-care company said in a statement Sunday a sale had been agreed with Luye Medical, a division of Luye Group which also has a significant stake in Hong Kong-listed Luye Pharma Group Ltd.

Acquired by Archer in mid-2011, Sydney-based Healthe Care operates 17 hospitals with more than 1,800 beds located in major cities and key regional areas across Australia. Under Archer, the company has teadily expanded with a series of acquisitions, including Townsville Private in 2014 and Robina Private earlier this year.

“There are very few private hospital portfolio acquisition opportunities anywhere in the world and to be able to enter the Australian market with an acquisition of scale such as Healthe Care represents a reat opportunity,” Luye Group Chairman Liu Dian Bo said.

He said the deal would provide the Chinese company with a platform to build a health-care services company in Australia, China and other parts of Asia.

Archer was advised on the deal by Luminis Partners and Morgan Stanley, while Luye Medical was advised by Barclays, the companies said in the statement. The acquisition is expected to be completed in the first quarter of 2016.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »